Role of interleukin-1beta in activating the CD11c(high) CD45RB- dendritic cell subset and priming Leishmania amazonensis-specific CD4+ T cells in vitro and in vivo.
Cutaneous leishmaniasis associated with Leishmania amazonensis infection is characterized by uncontrolled parasite replication and profound immunosuppression; however, the underlying mechanisms remain largely unclear. One possibility is that the L. amazonensis parasite modulates antigen-presenting cells, favoring the generation of pathogenic Th cells that are capable of recruiting leukocytes but insufficient to fully activate their microbicidal activities. To test this possibility, we infected bone marrow-derived dendritic cells (DCs) of C57BL/6 mice with L. amazonensis or Leishmania major promastigotes and assessed the activation of DC subsets and their capacity in priming CD4(+) T cells in vitro. In comparison to L. major controls, L. amazonensis-infected DCs secreted lower levels of interleukin-1alpha (IL-1alpha) and IL-1beta, were less potent in activating the IL-12p40-producing CD11c(high) CD45RB(-) CD83(+) CD40(+) DC subset, and preferentially activated CD4(+) T cells with a IFN-gamma(low) IL-10(high) IL-17(high) phenotype. Although the addition of IL-1beta at the time of infection markedly enhanced DC activation and T-cell priming, it did not skew the cytokine profile of DCs and pathogenic Th cells, as local injection of IL-1beta following L. amazonensis infection accelerated Th cell activation and disease progression. This study suggests that intrinsic defects at the level of DC activation are responsible for the susceptible phenotype in L. amazonensis-infected hosts and that this parasite may have evolved unique mechanisms to interfere with innate and adaptive immunity.
Xin
Lijun
L
Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555-1070, USA.
Li
Yongguo
Y
Soong
Lynn
L
D000818:Animals; D015703:Antigens, CD / Q000032:analysis; D039521:CD11c Antigen / Q000032:analysis; D015496:CD4-Positive T-Lymphocytes / Q000737:chemistry / Q000276:immunology*; D019013:CD40 Antigens / Q000032:analysis; D002478:Cells, Cultured; D003713:Dendritic Cells / Q000737:chemistry / Q000276:immunology* / Q000469:parasitology*; D005260:Female; D005434:Flow Cytometry; D007136:Immunoglobulins / Q000032:analysis; D007371:Interferon-gamma / Q000096:biosynthesis; D016753:Interleukin-10 / Q000032:analysis; D053762:Interleukin-12 Subunit p40 / Q000096:biosynthesis; D020381:Interleukin-17 / Q000032:analysis; D053582:Interleukin-1alpha / Q000096:biosynthesis; D053583:Interleukin-1beta / Q000096:biosynthesis / Q000276:immunology*; D007891:Leishmania / Q000276:immunology*; D017493:Leukocyte Common Antigens / Q000032:analysis; D008562:Membrane Glycoproteins / Q000032:analysis; D051379:Mice; D008810:Mice, Inbred C57BL; D016176:T-Lymphocyte Subsets / Q000276:immunology*; D000097802:CD83 Antigen
D015703:Antigens, CD; D039521:CD11c Antigen; D019013:CD40 Antigens; D007136:Immunoglobulins; D007371:Interferon-gamma; D016753:Interleukin-10; D053762:Interleukin-12 Subunit p40; D020381:Interleukin-17; D053582:Interleukin-1alpha; D053583:Interleukin-1beta; D017493:Leukocyte Common Antigens; D008562:Membrane Glycoproteins; D000097802:CD83 Antigen